Home
About
Overview
Sharing Data
ORCID
Help
History (63)
Pharmacologic Targeting of Red Blood Cells to Improve Tissue Oxygenation.
Nitric oxide released from activated platelets inhibits platelet recruitment.
The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.
.BRAF Mutation Analysis in Pulmonary Langerhans Cell Histiocytosis. 2011. Minisymposium presentation & Abstract at the United States and Canadian Academy of Pathology Annual Meeting, Vancouver BC (01/14/12)
IL-16 represses HIV-1 promoter activity.
See All 63 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IL-16 represses HIV-1 promoter activity.
Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, Viglianti GA. IL-16 represses HIV-1 promoter activity. J Immunol. 1997 Jan 01; 158(1):5-8.
View in:
PubMed
subject areas
Down-Regulation
Gene Products, tat
HIV Long Terminal Repeat
HIV-1
Humans
Interleukin-16
NF-kappa B
tat Gene Products, Human Immunodeficiency Virus
Virus Activation
authors with profiles
Hardy Kornfeld MD